What we've approved

Dealings involving intentional release

Details on the applications and licences for Dealings involving an intentional release (DIR) of a GMO into the environment.

Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.

Filter results

You can narrow down the results using the filters

Licence status

(-) Current (7)

Category

Agricultural (21)
(-) Medical (7)
Veterinary (2)

Release

Limited and controlled (11)
(-) Commercial (7)

Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.

7 results
Filters applied: Clear all
Licence number Project title Organisation Category Release Issue date Licence status
DIR 182

Commercial supply of a genetically modified COVID-19 vaccine

Janssen-Cilag Pty Ltd

 Medical Commercial Current
DIR 180

Commercial supply of a genetically modified COVID-19 vaccine

AstraZeneca Pty Ltd

 Medical Commercial Current
DIR 174

Commercial supply of a genetically modified cholera vaccine, Vaxchora®

Biocelect Pty Ltd

 Medical Commercial Current
DIR 148

Commercial supply of Dengvaxia, an attenuated GM dengue vaccine

Sanofi-Aventis Australia Pty Ltd

 Medical Commercial Current
DIR 137

Commercial supply of attenuated GM influenza vaccines

AstraZeneca Pty Ltd

 Medical Commercial Current
DIR 132

Commercial supply of a tumour-selective genetically modified virus for cancer therapy

Amgen Australia Pty Ltd

 Medical Commercial Current
DIR 098

Commercial release of a genetically modified live viral vaccine to protect against Japanese encephalitis (IMOJEV™)

Biocelect Pty Ltd

 Medical Commercial Current